Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Apr;114(3):230-4.
doi: 10.1016/j.clineuro.2011.10.022. Epub 2011 Nov 12.

Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy

Affiliations
Case Reports

Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy

Ebe Pastorello et al. Clin Neurol Neurosurg. 2012 Apr.

Abstract

Introduction: FacioScapuloHumeral Muscular Dystrophy (FSHD), a disease linked to a heterozygous D4Z4 deletion on chromosome 4q35, typically starts with shoulder-girdle and facial muscle involvement. Atypical presentations have occasionally been reported, but their frequency has still not been defined.

Patients and methods: We studied the occurrence rate of FSHD with atypical onset in 122 symptomatic subjects from 76 unrelated families with genetically confirmed FSHD. These 75 males and 47 females, with a mean age of 49 years (range: 11-85), had a mean EcoRI fragment of 25 kb (range: 11-38).

Results: Typical shoulder-girdle or facial weakness at onset was reported by 88 patients (72%). Unusual presentations included: foot drop in 16 (13%) and proximal lower limb weakness in eight patients (7%). Two cases at onset manifested quite atypical, apparently non-FSHD-related syndromes: a 42-year-old woman presented with infantile epilepsy and a 41-year-old man with myoglobinuria. In the latter patient, DNA analysis detected a 4q35 deletion associated to an heterozygous CAPN3 mutation.

Conclusion: FSHD presentation with foot drop or lower limb proximal weakness appeared to be more frequent than expected. This type of weakness at onset has to be considered premature, but still representative of disease-related muscle involvement. Quite atypical onset appears very rare and calls for further investigation on non-FSHD-related etiology.

PubMed Disclaimer

References

    1. Mostacciuolo M.L., Pastorello E., Vazza G., Miorin M., Angelini C., Trevisan C.P. Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a North-East Italian population sample. Clin Genet. 2009;75:550–555. - PubMed
    1. Norwood F.L., Harling C., Chinnery P.F., Eagle M., Bushby K., Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009;132:3175–3186. - PMC - PubMed
    1. Padberg G.W., van Engelen B.G. Facioscapulohumeral muscular dystrophy. Curr Opin Neurol. 2009;22:539–542. - PubMed
    1. Wijmenga C., Frants R.R., Brouwer O.F., Moerer P., Weber J.L., Padberg G.W. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet. 1990;336:651–653. - PubMed
    1. Van Deutekom J.C., Wijmenga C., Van Tienhoven E.A., Gruter A.M., Hewitt J.E., Padberg G.W. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet. 1993;12:2037–2042. - PubMed

Publication types

MeSH terms